KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Nektar Therapeutics (NKTR) over the last 15 years, with Q3 2025 value amounting to 0.25.

  • Nektar Therapeutics' Asset Utilization Ratio fell 1397.65% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 1397.65%. This contributed to the annual value of 0.28 for FY2024, which is 7250.69% up from last year.
  • Per Nektar Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.25 for Q3 2025, which was down 1397.65% from 0.32 recorded in Q2 2025.
  • Nektar Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.32 during Q2 2025, with a 5-year trough of 0.07 in Q2 2021.
  • Over the past 5 years, Nektar Therapeutics' median Asset Utilization Ratio value was 0.17 (recorded in 2023), while the average stood at 0.18.
  • As far as peak fluctuations go, Nektar Therapeutics' Asset Utilization Ratio crashed by 2799.26% in 2021, and later soared by 7378.61% in 2023.
  • Nektar Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.09 in 2021, then soared by 45.01% to 0.12 in 2022, then soared by 73.79% to 0.21 in 2023, then soared by 50.0% to 0.32 in 2024, then dropped by 23.53% to 0.25 in 2025.
  • Its last three reported values are 0.25 in Q3 2025, 0.32 for Q2 2025, and 0.31 during Q1 2025.